These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 39033578)

  • 1. Biocatalytic approach for the synthesis of chiral alcohols for the development of pharmaceutical intermediates and other industrial applications: A review.
    Naim M; Mohammat MF; Mohd Ariff PNA; Uzir MH
    Enzyme Microb Technol; 2024 Oct; 180():110483. PubMed ID: 39033578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods.
    Simić S; Zukić E; Schmermund L; Faber K; Winkler CK; Kroutil W
    Chem Rev; 2022 Jan; 122(1):1052-1126. PubMed ID: 34846124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocatalysis for the asymmetric synthesis of Active Pharmaceutical Ingredients (APIs): this time is for real.
    de Gonzalo G; Alcántara AR; Domínguez de María P; Sánchez-Montero JM
    Expert Opin Drug Discov; 2022 Oct; 17(10):1159-1171. PubMed ID: 36045591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New opportunities for biocatalysis: driving the synthesis of chiral chemicals.
    Zheng GW; Xu JH
    Curr Opin Biotechnol; 2011 Dec; 22(6):784-92. PubMed ID: 21783357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocatalysts for the pharmaceutical industry created by structure-guided directed evolution of stereoselective enzymes.
    Li G; Wang JB; Reetz MT
    Bioorg Med Chem; 2018 Apr; 26(7):1241-1251. PubMed ID: 28693917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in industrial biocatalysis.
    Nestl BM; Nebel BA; Hauer B
    Curr Opin Chem Biol; 2011 Apr; 15(2):187-93. PubMed ID: 21195018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New trends in the biocatalytic production of nucleosidic active pharmaceutical ingredients using 2'-deoxyribosyltransferases.
    Del Arco J; Acosta J; Fernández-Lucas J
    Biotechnol Adv; 2021 Nov; 51():107701. PubMed ID: 33515673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the development of new biocatalytic processes for practical pharmaceutical synthesis.
    Huisman GW; Collier SJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):284-92. PubMed ID: 23462589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in aldo-keto reductases immobilization for biocatalytic synthesis of chiral alcohols.
    Zhang W; Shao ZQ; Wang ZX; Ye YF; Li SF; Wang YJ
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133264. PubMed ID: 38901517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocatalysis for synthesis of pharmaceuticals.
    Patel RN
    Bioorg Med Chem; 2018 Apr; 26(7):1252-1274. PubMed ID: 28648492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the organic toolbox: a guide to integrating biocatalysis in synthesis.
    Clouthier CM; Pelletier JN
    Chem Soc Rev; 2012 Feb; 41(4):1585-605. PubMed ID: 22234546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly engineered biocatalysts for efficient small molecule pharmaceutical synthesis.
    Lalonde J
    Curr Opin Biotechnol; 2016 Dec; 42():152-158. PubMed ID: 27261887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in biocatalytic synthesis of pharmaceutical intermediates.
    Panke S; Wubbolts M
    Curr Opin Chem Biol; 2005 Apr; 9(2):188-94. PubMed ID: 15811804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocatalysis: A smart and green tool for the preparation of chiral drugs.
    Rossino G; Robescu MS; Licastro E; Tedesco C; Martello I; Maffei L; Vincenti G; Bavaro T; Collina S
    Chirality; 2022 Nov; 34(11):1403-1418. PubMed ID: 35929567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
    Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
    Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesizing Chiral Drug Intermediates by Biocatalysis.
    Jiang W; Fang B
    Appl Biochem Biotechnol; 2020 Sep; 192(1):146-179. PubMed ID: 32323141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates.
    Sun H; Zhang H; Ang EL; Zhao H
    Bioorg Med Chem; 2018 Apr; 26(7):1275-1284. PubMed ID: 28709846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocatalytic ketone reduction: a green and efficient access to enantiopure alcohols.
    Ni Y; Xu JH
    Biotechnol Adv; 2012; 30(6):1279-88. PubMed ID: 22079798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The limits to biocatalysis: pushing the envelope.
    Sheldon RA; Brady D
    Chem Commun (Camb); 2018 Jun; 54(48):6088-6104. PubMed ID: 29770379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.